FDA Review Panel · MG

FDA 510(k) Medical Genetics Devices

FDA 510(k) Medical Genetics Devices - Regulatory Overview

FDA 510(k) medical genetics devices include instruments and systems used for genetic analysis and molecular diagnostics. The FDA review panel code is MG.

This is a small but rapidly growing category as many genetic tests follow the PMA or De Novo pathway instead of 510(k). Current submissions include:

  • DNA sequencing systems - next-generation sequencing (NGS) platforms
  • PCR-based diagnostic systems - real-time PCR for genetic variant detection
  • Chromosomal analysis instruments - karyotyping and FISH systems

FDA 510(k) Review Time - Medical Genetics Panel

Period Avg days (cleared)
Last 2 years -
All-time average (cleared) 399d
Not Substantially Equivalent (denied) 515d

FDA review times for Medical Genetics submissions have remained consistent, averaging 399 days for cleared devices. Denied submissions averaged 515 days before receiving a Not Substantially Equivalent determination.

Compare review times across all FDA specialty panels →

19
Total
11
Cleared
399d
Avg (2y)
2016
Since

FDA 510(k) Cleared Medical Genetics Devices

This page lists all 19 medical devices in the Medical Genetics specialty that have been submitted to the FDA through the 510(k) premarket notification process. Genetic testing systems, molecular diagnostics and genomic analysis tools.

  • 11 devices cleared as substantially equivalent to a predicate device.
  • Average time to FDA decision: 399 days.
  • Records available from 2016 to the present.
  • Filter by product code using the sidebar to narrow results by device type.
15 Medical Genetics devices
1–15 of 15
Not Cleared Sep 19, 2025
KMT2A Breakapart FISH Probe Kit PDx (CDA-LPH013)
DEN240067 · Cytocell Limited
SFS · Revumenib Eligibility Detection System · 301d
Not Cleared Sep 29, 2023
Invitae Common Hereditary Cancers Panel
DEN210011 · Invitae Corporation
QVU · High Throughput Dna Sequencing For Hereditary Cancer Predisposition Assessment Test System. · 914d
Cleared Sep 05, 2023
BCR-ABL1 (p210) % IS Kit (Digital PCR Method)
K221869 · Suzhou Sniper Medical Technologies Co., Ltd.
OYX · Bcr/abl1 Monitoring Test · 434d
Cleared May 04, 2023
Bladder EpiCheck DNA extraction kit, NX899090-01C, Bladder EpiCheck test kit, NX899090-02C, Bladder EpiCheck Software, NX899090-03C
K203245 · Nucleix , Ltd.
MMW · System, Test, Tumor Marker, Monitoring, Bladder · 912d
Cleared Nov 09, 2022
Eonis SCID-SMA kit
K203035 · Perkinelmer, Inc.
PJI · Severe Combined Immunodeficiency Disorder (scid) Newborn Screening Test System · 765d
Not Cleared Nov 09, 2022
Eonis SCID-SMA Kit
DEN200044 · Perkinelmer, Inc.
QUE · Spinal Muscular Atrophy Newborn Screening Test System · 854d
Not Cleared May 24, 2022
Parsortix PC1 Device
DEN200062 · Angle Europe , Ltd.
QSA · Circulating Tumor Cell (ctc) Enrichment Device · 603d
Cleared Jan 06, 2022
23andMe PGS Genetic Risk Report for Hereditary Prostate Cancer (HOXB13-Related)
K211499 · 23AndMe, Inc.
QAZ · Cancer Predisposition Risk Assessment System · 237d
Not Cleared Dec 23, 2020
Helix Laboratory Platform
DEN190035 · Helix Opco, LLC
QNC · Whole Exome Sequencing Constituent Device · 509d
Cleared Aug 05, 2020
Adaptive Biotechnologies clonoSEQ Assay
K200009 · Adaptive Biotechnologies Corporation
QDC · Dna-based Test For Minimal Residual Disease For Hematologic Malignancies · 216d
Not Cleared Feb 21, 2020
AmplideX Fragile X Dx & Carrier Screen Kit
DEN190023 · Asuragen, Inc.
OYV · Inherited Nucleotide Repeat Disorder Dna Test · 309d
Cleared Feb 13, 2019
QXDx BCR-ABL %IS Kit for use on the QXDx AutoDG ddPCR System
K181661 · Bio-Rad Laboratories, Inc.
OYX · Bcr/abl1 Monitoring Test · 233d
Cleared Jan 18, 2019
MUTYH-Associated Polyposis (MAP)
K182784 · 23AndMe, Inc.
QAZ · Cancer Predisposition Risk Assessment System · 109d
Not Cleared Dec 21, 2018
MLL (KMT2A) Breakapart FISH Probe Kit
DEN170070 · Cytocell, Ltd.
QDI · Fish Based Detection Of Chromosomal Abnormalities From Patients With Hematologic Malignancies · 448d
Cleared May 08, 2018
VENTANA CD30 (Ber-H2) RxDx Assay
K172471 · Ventana Medical Systems, Inc.
DEH · Lambda, Antigen, Antiserum, Control · 266d

Using this Medical Genetics 510(k) Regulatory Dataset

This page lists 19 medical devices in the Medical Genetics specialty submitted to the FDA through the 510(k) premarket notification process. Of these, 11 were cleared as substantially equivalent to a predicate device. Average FDA review time: 399 days. Records from 2016 to the present.

You can use this list to:

  • Find predicate devices for a new 510(k) submission
  • Verify the clearance status of a specific device
  • Identify FDA product codes related to medical genetics
  • Compare similar cleared devices within this category
  • Research manufacturers active in this specialty

Each entry includes: device name, 510(k) number, product code, manufacturer and FDA decision date. Click any device to view the full submission details.

This information is based on publicly available FDA data and is intended for informational purposes only. It may not reflect current market or regulatory status. Always verify critical information at accessdata.fda.gov.

Filter by Product Code